CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)

26 August 2018 (08:30 - 12:30)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Mr Zhou Du

Peking University First Hospital, Beijing (China)

9 More presentations in this session

Presentation thumbnail

Doctor E. Kocianova (Olomouc, CZ)

Abstract Slides

Presentation thumbnail

Professor N. Izmozherova (Yekaterinburg, RU)

Presentation thumbnail

Doctor A. Farcas (Cluj Napoca, RO)

Presentation thumbnail

Professor Y. Takeda (Uchinada, JP)

Abstract Slides

Presentation thumbnail

Doctor T. Netchessova (Minsk, BY)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 2 - Hypertension treatment old and new

The Event

ESC Congress 2018

26 August 2018 08:30 CET

You may be interested in

Congress Presentation

Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension

25 August 2023

Congress Presentation

Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT

1 September 2025

Congress Presentation

Design of a multicenter, open-label, randomized controlled trial: effects of intensive systolic blood pressure lowering treatment in reducing risk of vascular events (ESPRIT)

2 September 2019

Congress Presentation

Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis

30 August 2020

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources